Mauna Kea Technologies SAS (ALMKT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Mauna Kea Technologies SAS (ALMKT) has a cash flow conversion efficiency ratio of 0.077x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-2.28 Million ≈ $-2.67 Million USD) by net assets (€-29.42 Million ≈ $-34.40 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Mauna Kea Technologies SAS market capitalisation for the company's overall valuation and market capitalisation.
Mauna Kea Technologies SAS - Cash Flow Conversion Efficiency Trend (2010–2024)
This chart illustrates how Mauna Kea Technologies SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Mauna Kea Technologies SAS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mauna Kea Technologies SAS ranked by their cash flow conversion efficiency. Explore cash flow quality index of Mauna Kea Technologies SAS to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bonava AB (publ)
ST:BONAV-A
|
-0.022x |
|
SGA Solutions Co.Ltd
KQ:184230
|
-0.097x |
|
Sangsin Brake
KO:041650
|
0.042x |
|
Tayih Lun An Co Ltd
TWO:8107
|
0.010x |
|
Censof Holdings Bhd
KLSE:5195
|
0.051x |
|
Yeou Yih Steel Co Ltd
TWO:9962
|
0.166x |
|
Systech Bhd
KLSE:0050
|
0.387x |
|
Dynamic Group Holdings Ltd
AU:DDB
|
0.331x |
Annual Cash Flow Conversion Efficiency for Mauna Kea Technologies SAS (2010–2024)
The table below shows the annual cash flow conversion efficiency of Mauna Kea Technologies SAS from 2010 to 2024. View Mauna Kea Technologies SAS (ALMKT) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | €-24.39 Million ≈ $-28.51 Million |
€-6.32 Million ≈ $-7.39 Million |
0.259x | +494.90% |
| 2023-12-31 | €-17.28 Million ≈ $-20.20 Million |
€-753.00K ≈ $-880.34K |
0.044x | -90.16% |
| 2022-12-31 | €-19.93 Million ≈ $-23.29 Million |
€-8.83 Million ≈ $-10.32 Million |
0.443x | -55.43% |
| 2021-12-31 | €-10.33 Million ≈ $-12.08 Million |
€-10.27 Million ≈ $-12.01 Million |
0.994x | +50.29% |
| 2020-12-31 | €-12.08 Million ≈ $-14.12 Million |
€-7.99 Million ≈ $-9.34 Million |
0.662x | +101.63% |
| 2019-12-31 | €253.00K ≈ $295.78K |
€-10.27 Million ≈ $-12.01 Million |
-40.601x | -2872.05% |
| 2018-12-31 | €7.98 Million ≈ $9.33 Million |
€-10.90 Million ≈ $-12.74 Million |
-1.366x | -134.80% |
| 2017-12-31 | €16.74 Million ≈ $19.58 Million |
€-9.74 Million ≈ $-11.39 Million |
-0.582x | +17.16% |
| 2016-12-31 | €11.16 Million ≈ $13.04 Million |
€-7.84 Million ≈ $-9.16 Million |
-0.702x | +15.62% |
| 2015-12-31 | €14.09 Million ≈ $16.47 Million |
€-11.73 Million ≈ $-13.71 Million |
-0.832x | -18.67% |
| 2014-12-31 | €18.15 Million ≈ $21.22 Million |
€-12.73 Million ≈ $-14.88 Million |
-0.701x | -120.08% |
| 2013-12-31 | €30.16 Million ≈ $35.26 Million |
€-9.61 Million ≈ $-11.24 Million |
-0.319x | +3.61% |
| 2012-12-31 | €40.16 Million ≈ $46.95 Million |
€-13.28 Million ≈ $-15.53 Million |
-0.331x | -176.02% |
| 2011-12-31 | €51.57 Million ≈ $60.30 Million |
€-6.18 Million ≈ $-7.22 Million |
-0.120x | +67.12% |
| 2010-12-31 | €6.86 Million ≈ $8.02 Million |
€-2.50 Million ≈ $-2.92 Million |
-0.364x | -- |
About Mauna Kea Technologies SAS
Mauna Kea Technologies SA manufactures and sells medical devices in Europe and internationally. It offers a range of medical devices for gastroenterology, pulmonology, and urology applications. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform that enables unique in vivo cellular visualization, allowing doctors to monitor disease evolution over time, evaluate… Read more